Domenech, Cristina
Altamura, Carlo
Bernasconi, Corrado
Corral, Ricardo
Elkis, Helio
Evans, Jonathan
Malla, Ashok
Krebs, Marie-Odile
Nordstroem, Anna-Lena
Zink, Mathias
Haro, Josep Maria http://orcid.org/0000-0002-3984-277X
Funding for this research was provided by:
F. Hoffmann-La Roche (Data base freely provided by Roche)
Article History
Received: 23 September 2017
Accepted: 2 January 2018
First Online: 16 January 2018
Compliance with ethical standards
:
: Cristina Domenech has no conflict of interest. Carlo Altamura has served as a consultant or advisory board member for F. Hoffmann-La Roche, Ltd., Lundbeck, Merck, Astra Zeneca, Bristol Myers Squibb, Janssen-Cilag, Sanofi, Eli Lilly, Pfizer and Otsuka. Corrado Bernasconi is a contractor of F. Hoffmann-La Roche, Ltd. Helio Elkis has received research grants from the São Paulo Research Foundation (FAPESP), Janssen-Cilag and Roche, participated on advisory boards for Janssen-Cilag and Roche, and received honoraria and travel support from Janssen-Cilag and Roche. Ashok Malla has received honoraria or participated in advisory boards or educational conferences or received research funding for investigator-initiated projects from Janssen Canada, Pfizer Canada, Bristol-Myers-Squib, F. Hoffmann- La Roche, Ltd., Otsuka, Lundbeck and Astra-Zeneca. Anna-Lena Nordstroem is an employee of F. Hoffmann-La Roche, Ltd. Mathias Zink has received unrestricted scientific grants from the European Research Advisory Board, German Research Foundation, Servier, Pfizer Pharma GmbH, Bristol-Myers Squibb GmbH & CoKGaA, and speaker and travel support from Pfizer Pharma GmbH, Bristol-Myers Squibb, Otsuka, Astra Zeneca, Eli-Lilly, Janssen Cilag, Servier, Trommsdorff and F. Hoffmann-La Roche Ltd. Marie-Odile Krebs has received honoraria from and participated in advisory boards for F. Hoffmann-La Roche, Ltd. Josep Maria Haro has acted as a consultant, participated in advisory boards or given educational presentations for Eli Lilly and Co., Lundbeck, Otsuka, F. Hoffmann-La Roche Ltd. and Takeda. Jonathan Evans and Ricardo Corral have no conflicts of interest.
: The protocol and consent procedures were approved by all local institute review boards/ethics committees before study initiation. All patients and caregivers provided informed consent.